Cargando…
Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms
BACKGROUND: Reduced activation of dopamine D(1) receptor signaling may be implicated in reward functioning as a potential driver of negative symptoms in schizophrenia. Phosphodiesterase 10A (PDE10A), an enzyme that is highly expressed in the striatum, modulates both dopamine D(2)- and D(1)-dependent...
Autores principales: | Umbricht, Daniel, Abt, Markus, Tamburri, Paul, Chatham, Christopher, Holiga, Štefan, Frank, Michael J., Collins, Anne G.E., Walling, David P., Mofsen, Rick, Gruener, Daniel, Gertsik, Lev, Sevigny, Jeff, Keswani, Sanjay, Dukart, Juergen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616307/ https://www.ncbi.nlm.nih.gov/pubmed/36324430 http://dx.doi.org/10.1016/j.bpsgos.2021.03.001 |
Ejemplares similares
-
S43. A PROOF-OF-MECHANISM STUDY OF THE PDE10 INHIBITOR RG7203 IN PATIENTS WITH PROBING REWARD FUNCTIONS WITH IMAGING AND BEHAVIORAL APPROACHES
por: Umbricht, Daniel, et al.
Publicado: (2018) -
The effect of risperidone on reward‐related brain activity is robust to drug‐induced vascular changes
por: Hawkins, Peter C. T., et al.
Publicado: (2021) -
Teleeducation: Pandemic Proofing Global Education
por: Michel, Janet, et al.
Publicado: (2022) -
Serum Levels of Adropin Improve the Predictability of MELD and Child-Pugh Score in Cirrhosis: Results of Proof-of-Concept Clinical Trial
por: Kolben, Yotam, et al.
Publicado: (2023) -
Trends and Outcomes of Hypothermic Machine Perfusion Preservation of Kidney Allografts in Simultaneous Liver and Kidney Transplantation in the United States
por: Chang, Alex, et al.
Publicado: (2022)